Literature DB >> 7207646

Differential effects of potassium on the potency of different opioids in the mouse vas deferens.

M Wüster, R Schulz.   

Abstract

The effect of potassium on the potency of different opioids to inhibit electrically evoked twitches of the mouse vas deferens has been studied. In general, opioids lose activity as the concentration of potassium increases. Distinct differences, however, were observed between specific opiate receptor agonists. Least sensitive to the effect of potassium proved mu- and delta-opiate receptor agonists, showing only a 2-fold increase in the concentration required to cause a half-maximal inhibition at 14 mM K+. In contrast, the supposed dynorphin receptor/kappa-receptor agonists exhibited at this concentration up to an 8-fold loss of potency. Dynorphin1-13 was found to be intermediate with a 5-fold loss of inhibitory activity. These data suggest a modulatory action of potassium for dynorphin- and kappa-receptors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7207646     DOI: 10.1007/bf00499262

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Regulation of glutamate receptors by cations.

Authors:  M Baudry; G Lynch
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

2.  Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.

Authors:  K J Chang; P Cuatrecasas
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

3.  Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides.

Authors:  A J Blume
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

4.  Effects of Na+, k+, mg++ and Ca++ on the saturable binding of [3H]dihydromorphine and [3H]naloxone in vitro.

Authors:  C Y Lee; T Akera; T M Brody
Journal:  J Pharmacol Exp Ther       Date:  1977-07       Impact factor: 4.030

5.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

6.  Enhancement by elevated external potassium of the maximal responses to acetylcholine and norepinephrine in the rat vas deferens.

Authors:  N Suzuki; Y Kasuya
Journal:  Eur J Pharmacol       Date:  1979-10-01       Impact factor: 4.432

7.  Serotonin receptor binding sites affected differentially by guanine nucleotides.

Authors:  S J Peroutka; R M Lebovitz; S H Snyder
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

Review 8.  Multiple neurotransmitter receptors.

Authors:  S H Snyder; R R Goodman
Journal:  J Neurochem       Date:  1980-07       Impact factor: 5.372

9.  The direction of opiodid agonists towards mu-, delta- and epsilon-receptors in the vas deferens of the mouse and the rat.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Life Sci       Date:  1980-07-14       Impact factor: 5.037

10.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

View more
  1 in total

Review 1.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.